Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$12.5M Sell
220,480
-17,113
-7% -$961K 1.06% 21
2014
Q2
$13.1M Buy
237,593
+18,640
+9% +$1.02M 1.11% 16
2014
Q1
$11.9M Buy
218,953
+11,455
+6% +$593K 1.02% 20
2013
Q4
$9.91M Sell
207,498
-917
-0.4% -$41.9K 0.7% 31
2013
Q3
$9.47M Buy
208,415
+49,770
+31% +$2.27M 0.84% 28
2013
Q2
$7.03M Buy
+158,645
New +$7.09M 1.38% 23

Other funds holding MRK

Banyan Partners's MRK Position: Q3 2014 in Review

Banyan Partners reduced its Merck (MRK) stake by 7.2% in Q3 2014, selling an estimated $961K and leaving 220,480 shares worth $12.5M. The position accounts for 1.06% of the portfolio, ranked #21.

Banyan Partners first reported a position in MRK in Q2 2013 and has held it in 6 quarters since. The position peaked at $13.1M in Q2 2014. 1,617 funds tracked by Wall St. Rank hold MRK as of Q3 2014.

  • Banyan Partners held 220,480 shares of Merck worth $12.5M as of Q3 2014.
  • Banyan Partners sold 17,113 Merck shares in Q3 2014, an estimated $961K.
  • Merck made up 1.06% of Banyan Partners's portfolio in Q3 2014, its #21 holding.
  • Banyan Partners first reported a position in Merck in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Merck position peaked at $13.1M in Q2 2014.
  • 1,617 funds tracked by Wall St. Rank held Merck as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.